MedTrace Logo

Locally Advanced Pancreatic Cancer After Systemic Therapy: Ablative MR-guided Radiotherapy

NCT06272162 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2024-02-22

No results posted yet for this study

Summary

A randomized controlled trial comparing the effect of local ablative MR-guided radiotherapy (MRgRT) after systemic therapy with current standard treatment alone, on health-related quality of life in patients with locally advanced pancreatic cancer (LAPC).

Conditions

  • Locally Advanced Pancreatic Adenocarcinoma

Interventions

RADIATION

MR guided radiotherapy

5 fractions of 10 Gray MRgRT in addition to standard of care

Sponsors & Collaborators

  • Amsterdam UMC, location VUmc

    collaborator OTHER

  • Radboud University Medical Center

    collaborator OTHER

  • Catharina Ziekenhuis Eindhoven

    collaborator OTHER

  • Centre for Human Drug Research, Netherlands

    collaborator OTHER

  • Dutch Pancreatic Cancer Group (DPCG)

    collaborator UNKNOWN

  • UMC Utrecht

    lead OTHER

Principal Investigators

  • L. A. Daamen, MD, PhD · Regional Academic Cancer Center Utrecht (RACU)

  • M P.W. Intven, MD, PhD · Regional Academic Cancer Center Utrecht (RACU)

  • A. M.E. Bruynzeel, MD, PhD · Amsterdam University Medical Center, VUmc

  • H. D. Heerkens, MD, PhD · Radboud University Medical Center

  • H. M.U. Peulen, MD, PhD · Catharina Ziekenhuis Eindhoven

  • J. J. Bosch · Centre of Human Drug Research

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-02-29
Primary Completion
2030-01-31
Completion
2030-01-31

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06272162 on ClinicalTrials.gov